Health AI Central
Peer-Reviewed Publication
Cancer Res Commun2026;6(9):2079-2089.September 1, 2026Journal Article

Neighborhood Factors and Treatment Outcomes in Pediatric Acute Lymphoblastic Leukemia: A REDIAL Consortium Report.

Rutu A Rathod1,2,3, Amy E Hughes3,4, Pagna Sok5, Karen R Rabin5,6,7, Sandi L Pruitt3,4, Philip J Lupo5,6,8,9, Michael E Scheurer5,6,8,9, Jeremy M Schraw5,6,
1Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
2Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
3Peter O'Donnell School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas.
4Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
5Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
6Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.
7Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, California.
8Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
9Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
PubMed DOI

Abstract

UNLABELLED: Acute lymphoblastic leukemia (ALL) shows persistent outcome disparities among socioeconomically disadvantaged and Hispanic children. Neighborhood socioeconomic status (nSES) and residence in Hispanic enclaves may contribute to these disparities, yet their impact on pediatric ALL is unclear. We examined associations of nSES and Hispanic enclave residence with ALL treatment outcomes. We…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.